Mechanism of Zhinao Capsule in Treating Alzheimer’s Disease Based on Network Pharmacology Analysis and Molecular Docking Validation

Figure 7

Molecular docking of ZNC components and AD-related targets using the SwissDock server. (a) CASP3 and beta-sitosterol; (b) TNF-α and quercetin; (c) VEGFA and baicalein; (d) MAPK1 and quercetin.

(a)

(b)

(c)

(d)